99mTc-Tetrofosmin myocardial perfusion imaging: A comparison with coronary angiography;Myokard-Perfusionsszintigraphie mit 99mTc-Tetrofosmin: Ein Vergleich mit der koronaren Angiographie

NuklearMedizin

Volumn 35, Issue 5, 1996, Pages 153-155

  Georgoulias, P ^a   Demakopoulos, N ^a   Kontos, A ^a,c   Xaplanteris, P ^a   Thomadakis, K ^a   Mortzos, G ^a   Karkavitsas, N ^b  

^a Veterans' Hospital (NIMTS)   (Greece)

^b Universitätsklinik   (Greece)

^c Arzt für Nuklearmedizin   (Greece)

Author keywords

99mTc tetrofosmin; coronary angiography; myocardial perfusion imaging; single photon emission tomography

Indexed keywords

TETROFOSMIN TC 99M; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE PERFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPARATIVE STUDY; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029658281     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629800     Document Type: Article

References (19)

1. Adachi I, Sugioka Y, Tanaka Y, Ogura Y, Nakata Y, Namba R, Tatsu Y, Nishigaki H et al. Clinical Efficacy of Tc-99m-Tetrofosmin Myocardial Scintigraphy. A Comparison to Tl-201 Myocardial Scintigraphy. Jpn J Nucl Med 1993; 30: 351-62.
2. Hendel RC, Parker P, Wackers FJ, Rigo P, Lahiri A, Cload P, Zaret DL. Tetrofosmin Study Group. Is interpretation of myocardial perfusion scans more consistent with Tc-99m-Tetrofosmin than Tl-201? Circulation 1993; 88: 1440.
3. Higley B, Smith FW, Smith T, Gemmel HG, Das-Gupta P, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A. Technetium-99m-1,2-bis (bis (2-ethoxyethyl) phospino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion agent J Nucl Med 1993; 34. 30-8.
4. Inoue Y, Machida K, Honda N, Mamiya T, Takahashi T, Kamano T, Kashimada A. Clearance Tc-99m-Tetrofosmin from the Myocardium and the Adjacent Organs. Jpn J Nucl Med 1993; 30: 313-6.
5. Jain D, Mattera JA, Sinusas A, McMahon M, Zaret BL, Wackers FJT. Biokinetics of Tc-99m-Tetrofosmin. A new myocardial perfusion imaging agent implications for one day imaging protocol. (Abstract) J Nucl Med 1992; 33: 874.
6. Jain D, Wackers FJT, McMahon M, Zaret BL. Is there any Redistribution with Tc-99m-Tetrofosmin Imaging? A Quantitative Study using Serial Planar Imaging. (Abstract) Circulation 1992; 86: 146.
7. Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of Tc-99m-Tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993; 34: 1254-9.
8. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, Chiu KW, Edwards B, Gill HK, McPartlin M et al. Tc-99m-Tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-7.
9. Kubo A, Nakamura K, Hashimoto J, Sammiya T, Iwanaga S, Hashimoto S, Sasaki Y. Phase I Clinical Trial of a New Myocardial Imaging Agent Tc-99m PPN1011. Jpn J Nucl Med 1992; 29: 1165-76.
10. Lakkis NM, Afridi I, Mahmarian JJ, Guidry GW, Verani MS. Tc-99m-Tetrofosmin perfusion imaging: analysis of heart, lung and liver kinetics after dipyridamole and at rest. J Am Coll Cardiol 1994, 254A.
11. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with Tc-99m-Tetrofosmin. J Nucl Med 1993; 34-1478-84.
12. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Tc-99m-Tetrofosmin myocardial imaging: a comparison with Tl-201 and angiography. J Nucl Med 1994; 35: 587-93.
13. Sinusas AJ, Shi QX, Saltzberg MT, Chang PI, Vitols PJ, Jain D, Wackers FJT, Zaret BL. Tc-99m-Tetrofosmin for Assessment of Myocardial Perfusion Initial Distribution and Clearance Relationship. (Abstract) J Nucl Med 1992; 33: 993.
14. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with Tc-99m-Tetrofosmin vs Tl-201 in coronary artery disease. Am J Cardiol 1993; 72: 1015-9.
15. Sridhara B, Sochor H, Rigo P, Braat S, Itti R, Martinez-Duncker D, Cload P, Lahiri A. Myocardial single-photon emission computed tomographic imaging with Tc-99m-Tetrofosmin. stress-rest imaging with same-day and separate-day imaging. J Nucl Cardiol 1994; 1: 138-43.
16. Takahasi N, Tamaki N, Tadamura E, Kawamoto M, Tonzuka T, Yonekura Y, Okuda K, Nohara R, Sasayma S, Konishi J. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin. J Nucl Cardiol 1994; 1: 29-38.
17. Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura E, Yonekura Y, Okuda K, Nohara R, Sasayama S, Konishi J. Myocardial tomography using Tc-99m-Tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
18. Uehara T, Toyama T, Hayashida K, Ishida Y, Shimonagata T, Nishimura T. Diagnosis of ischemic heart disease by using exercise and rest myocardial scintigraphy using Tc-99m PPN 1011 Tetrofosmin. (Abstract) J Nucl Med 1993; 34: 120.
19. Zaret BL, Lahiri A et al. Comparative Perfusion Scintigraphy with Tc-99m-Tetrofosmin and Tl-201 Results of the Phase III International Trial. (Abstract) Eur Heart J 1993; 14: 188.